Allergan Unanimously Rejects Revised Valeant Bid

June 10 (Bloomberg) -- Bloomberg’s Betty Liu reports that Allergan’s board has unanimously rejected an improved offer from Valeant, claiming it undervalues the company. She speaks on Bloomberg Television’s “In The Loop.”

Full Show: Bloomberg Businessweek (03/24)
04:19 - Bloomberg Television takes you behind the scenes of our award-winning magazine "Bloomberg Businessweek." Hosts Carol Massar and Oliver Renick talk with the writers who break news on a weekly basis. (Source: Bloomberg)
  • S&P 500 Winners and Losers for 03/24
  • Full Show: Best of Bloomberg Markets Middle East (03/24)
  • How to Trade the Health Care Select Sector SPDR Fund